Holen Sie sich die Stockscreener-App
91.96
0.14%
0.13
Handel nachbörslich:
91.94
-0.02
-0.02%
Schlusskurs vom Vortag:
$91.83
Offen:
$92.14
24-Stunden-Volumen:
12.50M
Relative Volume:
1.65
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-11.18%
1M Leistung:
-7.88%
6M Leistung:
+0.86%
1J Leistung:
+26.56%
1-Tages-Spanne:
$91.08
$92.74
1-Wochen-Bereich:
$91.08
$103.17
52-Wochen-Spanne:
$71.98
$105.47
Spdr Biotech Etf Stock (XBI) Company Profile
Firmenname
Spdr Biotech Etf
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie XBI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| XBI | 91.96 | 0 | 0 | 0 | 0 | 0.00 |
| VTI | 291.49 | 417.53B | 0 | 0 | 0 | 0.00 |
| SPY | 588.15 | 372.57B | 0 | 0 | 0 | 0.00 |
| IVV | 591.11 | 253.41B | 0 | 0 | 0 | 0.00 |
| VB | 247.33 | 160.59B | 0 | 0 | 0 | 0.00 |
| QQQ | 500.02 | 124.43B | 0 | 0 | 0 | 0.00 |
Spdr Biotech Etf Aktie (XBI) Neueste Nachrichten
Why Big Pharmaceuticals and Biotech Shares Fell - Baystreet.ca
StockWatch: Vaccine, ETF Shares Drop as Trump Chooses RFK Jr. for HHS - Genetic Engineering & Biotechnology News
Notable Two Hundred Day Moving Average CrossXBI - Nasdaq
5 Biggest Biotechnology ETFs in 2024 - Nasdaq
Steady Rate Cuts Feed Surging Biotech ETF SBIO - ETF Trends
What to Watch for Amid Biotech’s Resurgence - Money and Markets
(XBI) Pivots Trading Plans and Risk Controls - Stock Traders Daily
7 Best-Performing Biotech ETFs for November 2024 - NerdWallet
(XBI) Investment Analysis and Advice - Stock Traders Daily
The 5 Best Biotech ETFs of 2024 - TradingView
Best Biotech ETFs to Watch Right Now - The Motley Fool
XBI: Biotech ETF Is A Must Have (NYSEARCA:XBI) - Seeking Alpha
(XBI) Technical Pivots with Risk Controls - Stock Traders Daily
Capitulation in biotech is near, as well as a rally – Piper Sandler (NYSEARCA:XBI) - Seeking Alpha
Biotech and Retail ETFs have the highest implied call return, according to Goldman - Seeking Alpha
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now? - TradingView
8 Charts Suggesting Stock Market Pullback Could Deepen in the Near-Term - Investing.com
How To Trade (XBI) - Stock Traders Daily
Should You Invest in the SPDR S&P Biotech ETF (XBI)? - Yahoo Finance
6 Best Health Care ETFs to Buy Now | Investing - U.S News & World Report Money
SPDR Bloomberg Short Term High Yield Bond ETF (NYSEARCA:SJNK) Reaches New 1-Year High at $25.74 - Defense World
Biotech IPOs return as sector recovers after funding overhang - Seeking Alpha
Where are the Opportunities in (XBI) - Stock Traders Daily
(09/26/24) BCYC: A Promising Play in the Biotech Sector - Moneyshow.com
Biotech Boom Ahead? Key Stocks and ETFs to Watch Now - MSN
XBI Is Breaking Out And Likely To Outperform In The Near Term (Technical Analysis) - Seeking Alpha
Objective long/short (XBI) Report - Stock Traders Daily
Why Biotech ETFs Are Beating the Market - TradingView
Biotech Stocks Look Ready to Rally - Barron's
Biotech stocks poised for a comeback as interest rates fall - ShareCafe
Biotech Stocks Are Showing Signs of Life. Why the Rally Could Continue. - MSN
Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? - Yahoo Finance
3 Biotech ETFs for a Diversified Portfolio - Inkl
IBB: 3 Biotech ETFs for a Diversified Portfolio - StockNews.com
2 Biotech Stocks to Buy Hand Over Fist in August - MSN
Mather Group LLC. Increases Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
(XBI) Trading Report - Stock Traders Daily
2 Biotech Stocks Making Moves Today - Schaeffers Research
Form 424B2 BofA Finance LLC - StreetInsider.com
XBI, EXAS, UTHR, SRPT: Large Inflows Detected at ETF - Nasdaq
3 Biotech Names With Potential Catalysts By Year End - Seeking Alpha
Life May Soon Get Easier for (Some) Biotech Stocks. Here's Why. - sharewise
Osaic Holdings Inc. Acquires 179 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Biotech ETF (XBI) rallied from the blue box hitting target - FXStreet
Finanzdaten der Spdr Biotech Etf-Aktie (XBI)
Es liegen keine Finanzdaten für Spdr Biotech Etf (XBI) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.46%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):